166 related articles for article (PubMed ID: 32163508)
1. A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.
Walsh P; Lebedev M; McEligot H; Mutua V; Bang H; Gershwin LJ
PLoS One; 2020; 15(3):e0230245. PubMed ID: 32163508
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model.
Walsh P; Behrens N; Carvallo Chaigneau FR; McEligot H; Agrawal K; Newman JW; Anderson M; Gershwin LJ
PLoS One; 2016; 11(4):e0152913. PubMed ID: 27073858
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil extracellular traps (NETs) in a randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.
Mutua V; Cavallo F; Gershwin LJ
Vet Immunol Immunopathol; 2021 Nov; 241():110323. PubMed ID: 34543829
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.
Carvallo Chaigneau FR; Walsh P; Lebedev M; Mutua V; McEligot H; Bang H; Gershwin LJ
PLoS One; 2021; 16(6):e0252455. PubMed ID: 34111152
[TBL] [Abstract][Full Text] [Related]
5. Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor.
Lebedev M; McEligot HA; Mutua VN; Walsh P; Carvallo Chaigneau FR; Gershwin LJ
PLoS One; 2021; 16(2):e0246695. PubMed ID: 33600498
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein.
DeVincenzo J; Tait D; Efthimiou J; Mori J; Kim YI; Thomas E; Wilson L; Harland R; Mathews N; Cockerill S; Powell K; Littler E
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712214
[TBL] [Abstract][Full Text] [Related]
9. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
Cunningham S; Piedra PA; Martinon-Torres F; Szymanski H; Brackeva B; Dombrecht E; Detalle L; Fleurinck C;
Lancet Respir Med; 2021 Jan; 9(1):21-32. PubMed ID: 33002427
[TBL] [Abstract][Full Text] [Related]
10. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
[TBL] [Abstract][Full Text] [Related]
11. Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study.
DeVincenzo JP; McClure MW; Symons JA; Fathi H; Westland C; Chanda S; Lambkin-Williams R; Smith P; Zhang Q; Beigelman L; Blatt LM; Fry J
N Engl J Med; 2015 Nov; 373(21):2048-58. PubMed ID: 26580997
[TBL] [Abstract][Full Text] [Related]
12. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
[TBL] [Abstract][Full Text] [Related]
13. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of a 10-day course of ibuprofen in Holstein calves.
Walsh P; Carvallo Chaigneau FR; Anderson M; Behrens N; McEligot H; Gunnarson B; Gershwin LJ
J Vet Pharmacol Ther; 2016 Oct; 39(5):518-21. PubMed ID: 26876241
[TBL] [Abstract][Full Text] [Related]
16. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
17. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
[TBL] [Abstract][Full Text] [Related]
18. Oral GS-5806 activity in a respiratory syncytial virus challenge study.
DeVincenzo JP; Whitley RJ; Mackman RL; Scaglioni-Weinlich C; Harrison L; Farrell E; McBride S; Lambkin-Williams R; Jordan R; Xin Y; Ramanathan S; O'Riordan T; Lewis SA; Li X; Toback SL; Lin SL; Chien JW
N Engl J Med; 2014 Aug; 371(8):711-22. PubMed ID: 25140957
[TBL] [Abstract][Full Text] [Related]
19. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
